D- erythro MAPP structure
|
Common Name | D- erythro MAPP | ||
---|---|---|---|---|
CAS Number | 143492-38-0 | Molecular Weight | 361.561 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 536.7±43.0 °C at 760 mmHg | |
Molecular Formula | C23H39NO2 | Melting Point | 82ºC to 84ºC | |
MSDS | N/A | Flash Point | 278.4±28.2 °C |
Use of D- erythro MAPPD-erythro-MAPP (D-e-MAPP) is a ceramidase inhibitor, with an IC50 of 1-5 μM in vitro[1]. |
Name | N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]tetradecanamide |
---|---|
Synonym | More Synonyms |
Description | D-erythro-MAPP (D-e-MAPP) is a ceramidase inhibitor, with an IC50 of 1-5 μM in vitro[1]. |
---|---|
Related Catalog | |
In Vitro | D-erythro-MAPP (D-e-MAPP) reduces the viability of MCF-7 cells in a dose-dependent manner with IC50 value of 4.4 μM, and 15.6 μM, respectively[1]. D-erythro-MAPP (D-e-MAPP) induces G0/G1 arrest in cell cycle progression resulting in growth suppression[2]. Cell Viability Assay[1] Cell Line: Human breast cancer MCF-7 cells. Concentration: 24 h. Incubation Time: 3.13-100 μM. Result: Inhibited cell viability. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 536.7±43.0 °C at 760 mmHg |
Melting Point | 82ºC to 84ºC |
Molecular Formula | C23H39NO2 |
Molecular Weight | 361.561 |
Flash Point | 278.4±28.2 °C |
Exact Mass | 361.298065 |
PSA | 49.33000 |
LogP | 6.92 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.502 |
N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]tetradecanamide |
Tetradecanamide, N-[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]- |
MAPP,D-erythro |
N-[(1S,2R)-1-Hydroxy-1-phenyl-2-propanyl]tetradecanamide |
D-erythro-MAPP |